August 2026
Produced on 12 August 2026 at 12:00 based on data submitted up until and including 5 August 2026
Epidemiological summary
Findings from human surveillance
In 2026, and as at 5 August, seven countries in Europe have reported 245 locally acquired1 human cases of West Nile Virus (WNV) infection. The earliest and latest date of onset were on 12 May 2026 and 1 August 2026, respectively. Locally acquired cases have been reported by Italy (139 cases), Greece (65, of which four with unknown place of infection), Spain (17 cases), North Macedonia (13 cases), Romania (six cases), France (four cases) and Germany (one case). In Europe, 12 deaths have been reported by Greece (six deaths), Italy (five deaths) and Romania (one death).
The number of human cases reported so far (245 cases) is below the average for the corresponding period over the past decade (403 cases). However, reporting delays may result in an under-estimation of the current burden, as the 2026 data remain provisional, whereas the ten-year average is based on consolidated data from previous years. In addition, this ten-year average is influenced by several particularly intense WNV transmission seasons, notably in 2018 (1 065 cases reported up to the corresponding week), 2022 (781 cases) and 2024 (654 cases).
To date, most cases have been reported in Italy (139 cases) and Greece (65 cases). Although the number of cases reported in Italy is lower than during the same period in 2025 (168 cases), it remains the most affected country in Europe in 2026. Greece has reported more cases in 2026 than during the same period in 2025 (65 cases compared with 26 cases). WNV circulation is currently most intense in the Attica NUTS 2 region (48 cases), with Anatoliki Attiki (East Attica, 34 cases) and Voreios Tomeas Athinon (North Athens, seven cases) most affected.
As at 5 August 2026, locally acquired human cases of WNV infection had been reported in 58 NUTS 3 regions across seven countries. This is higher than at the same point in 2025, when cases were reported in 40 NUTS 3 regions across six countries. However, the geographical spread observed so far in 2026 remains well below the final extent recorded in recent seasons: by the end of 2025, affected regions numbered 160 and in 2024 there were 218. The 2024 season remains the largest WNV season on record in terms of geographical spread.
This year, six regions reported locally acquired human cases of WNV infection for the first time ever: France in Pyrénées-Orientales (FRJ15); Germany in Rhein-Pfalz-Kreis (DEB3I); Italy in Campobasso (ITF22) and Viterbo (ITI41); North Macedonia in Pelagoniski (MK005) and Vardarski (MK001).
Similar to previous years, most cases were reported among males aged 65 years and above. Most cases were hospitalised (72%) and presented with neurological symptoms (58%). The proportion hospitalised was lower than the average reported during the previous decade (87%), while the proportion with neurological symptoms was also slightly lower than the historical 10-year average (64%). The case fatality rate was approximately 5%, lower than the average reported during the previous decade (11%). However, this estimate should be interpreted with caution, as clinical outcomes may not yet be known for all reported cases and additional deaths may be recorded as the season progresses and data are consolidated.
Owing to delays in diagnosis and reporting, and because most WNV infections are asymptomatic or subclinical, the reported case numbers probably underestimate the true number of infections. Seasonal surveillance in humans primarily captures laboratory-confirmed cases, which may further contribute to reporting delays.
Findings from veterinary surveillance
From the veterinary perspective, 17 WNV outbreaks among equids and 74 outbreaks among birds have been reported in Europe in 2026. The earliest start date of an outbreak among equids and birds was on 30 March 2026 in France and 31 March 2026 in Italy, while the latest onset of an outbreak among equids and birds was, respectively, on 31 July 2026 in Netherlands and 28 July 2026 in Italy. Outbreaks among equids have been reported by France (five outbreaks), Greece (five outbreaks), Italy (five outbreaks), the Netherlands (one outbreak) and Spain (one outbreak). Outbreaks among birds have been reported by Italy (64 outbreaks), France (five outbreaks), Spain (three outbreaks), Austria (one outbreak) and Belgium (one outbreak).
No information was available on the equid species involved in the outbreaks reported in the Animal Disease Information System (ADIS). The bird species most frequently associated with the reported outbreaks were the common magpie (23) and the hooded crow (20), followed by the carrion crow (5), the common kestrel (5), the Eurasian blackbird (5), the yellow-legged gull (3), Adalbert’s eagle (2), the common wood-pigeon (2), and the little owl (2). Single outbreaks were associated with the common loon, the common raven, the European turtle-dove, the golden eagle, the grey heron, the house sparrow and the northern goshawk.
The monthly number of WNV outbreaks in equids reported during the first part of 2026 was comparable to the corresponding 10-year monthly average (2016−-2025). However, the number of equid outbreaks in July 2026 remained below the levels observed in July 2018, 2024 and 2025, years characterised by particularly high WNV intensity. In contrast, the number of WNV outbreaks in birds slightly exceeded the corresponding four-year monthly average (2022–2025) in April and May, and was substantially higher in June. This trend reversed in July 2026, when the number of reported outbreaks in birds fell below the four-year average, although it remained higher than in July 2025. However, it should be noted that reporting delays may affect the July numbers, as some outbreaks occurring during that month may be notified in August.
As at 5 August 2026, outbreaks in birds and/or equids have been reported in 43 NUTS 3 regions across seven countries. This compares with 55 regions (10 countries) during the same period in 2025 and 42 regions (eight countries) in 2024. All seven countries reported WNV outbreaks in birds and/or equids in 2025 and in prior years, reflecting endemic WNV activity in these territories. However, as at 5 August, outbreaks in birds and/or equids were reported to ADIS for the first time in the following six regions: by France in Hauts-de-Seine (FR105) and Seine-et-Marne (FR102); by Belgium in Arr. Namur (BE352), by Greece in Drama (EL514), by Italy in Genova (ITC33) and by the Netherlands in Delf en Westland (NL362).
Patterns across human and veterinary surveillance
Four countries – France, Greece, Italy, and Spain – reported both human WNV infections and outbreaks in equids and/or birds. As at 5 August, Italy accounted for most of the reported human cases (56.7%) and animal outbreaks (75.8%). Greece reported the second-largest share of human cases (26.5%) but only five equid outbreaks and no bird outbreaks, representing 5.5% of all reported animal outbreaks.
Differences in the patterns observed across European countries may reflect a combination of ecological, climatic and surveillance-related factors. Favourable climatic conditions and the presence of ecological hotspots, such as wetlands and agricultural areas, may support mosquito vector populations and influence the distribution and behaviour of animal hosts, thereby facilitating WNV circulation. At the same time, differences in WNV surveillance systems across Europe may affect detection and reporting rates.
The first indication of WNV activity may arise from either human or animal surveillance, depending on local epidemiology, detection capacity and surveillance system sensitivity. Therefore, the absence of reports from one sector should not be interpreted as evidence that WNV is not circulating. In France (Pyrénées-Orientales, FRJ15), Greece (Drama, EL514), and Italy (Genova, ITC33), human cases were reported before, or in the absence of, notified outbreaks in birds or equids. Conversely, in Belgium (Arr. Namur, BE352), France (Hauts-de-Seine, FR105 and Seine-et-Marne, FR102) and the Netherlands (Delft en Westland, NL362), animal detections preceded human cases. Belgium is a relevant example, as WNV was first reported in the country in 2025 through avian surveillance, with no previous detections in humans and animals. In 2026, it has again been identified in birds in a previously unaffected region, highlighting the role of avian surveillance in detecting local virus circulation and geographical spread.
Active mosquito surveillance is also important for the early detection of WNV circulation. However, results on WNV detection in mosquitoes are not included in this report because they are not legally required to be reported at European level, and the available information is therefore scattered and often project-based.
Seasonal outlook
Given the favourable weather conditions for WNV transmission in Europe, ECDC and EFSA expect further human cases and outbreaks in equids and birds to be reported in the coming weeks. In previous years, transmission has typically peaked in August and September.
ECDC and EFSA continue to closely monitor the situation in Europe.
Introduction
In the context of their ‘One Health’ activities, the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA) conduct joint surveillance of West Nile virus (WNV) infections in humans, equids, and birds, while also assessing the epidemiological situation in Europe. This initiative aims to inform public health and veterinary authorities in Europe, facilitating the implementation of prevention and control measures. These measures include the deferral or testing of blood donors who have potentially been exposed to the virus, in accordance with Commission Directives Commission Directives 2004/33/EC and 2014/110/EU.
The tables and maps in this monthly report show the countries and areas where human cases of WNV infection and outbreaks among equids and birds have been reported to the European surveillance portal for infectious diseases (EpiPulse Cases) and the Animal Disease Information System (ADIS). In addition to this monthly report, ECDC provides a weekly report presenting the locally acquired WNV infections among humans in Europe2.
For the analysis of ADIS outbreak data, this report includes only animal outbreaks with a ‘suspicion/start date’ in 2026. For analysis of historical data, when the ‘suspicion/start date’ was not reported, the ‘confirmation date’ was used instead. Outbreaks of WNV in animals shall be notified to ADIS in accordance with the provisions and definitions laid down in Commission Implementing Regulation (EU) 2020/2002. Under this Regulation, the reporting obligation applies to EU Member States; however, data from non-EU countries may also be available in ADIS. A notified outbreak may include one or more WNV cases. Since there is no specific case definition for WNV infection in animals, the general definition provided in Article 9 of Commission Delegated Regulation (EU) 2020/689 applies. When comparing the number of WNV outbreaks in birds reported in 2026 with historical data, a four-year average (2022–2025) was used – rather than the 10-year average applied to equids – since mandatory reporting of WNV outbreaks in birds only began in April 2021.
Overview of WNV cases in Europe
Table 1. Number of locally acquired human cases of WNV infections and number of WNV outbreaks among equids and birds reported within Europe in 2026 by reporting country and region of infection (NUTS 3 or GAUL 1 level), at 5 August 2026 .
When importing data.csv in MS Excel, please do not forget to select Unicode (UTF-8) as encoding.
Epicurves
Human cases
Overall (weekly)
Figure 1. Number of locally acquired human cases of WNV infections reported within Europe in 2026, by week and at 5 August 2026.
By country (weekly)
Figure 2. Number of locally acquired human cases of WNV infections reported within Europe in 2026, by country and at 5 August 2026.
Overall (monthly)
Figure 3. Number of locally acquired human cases of WNV infections reported within Europe in 2026, by month, and during the previous 10 years, at 5 August 2026.
By country (monthly)
Figure 4. Distribution of locally acquired human cases of WNV infections reported within Europe in 2026, and during the previous 10 years, at 5 August 2026.
Comparison (weekly)
Figure 5. Comparison of distributions of locally acquired human cases of WNV infections reported within Europe in 2026, and during the previous 5 years, at 5 August 2026.
Comparison, by country (weekly)
Figure 6. Comparison of distributions of locally acquired human cases of WNV infections reported within Europe in 2026, and during the previous 5 years, at 5 August 2026.
Outbreaks among equids and birds
Overall (weekly) - Current season
Figure 7. Number of WNV outbreaks among equids and birds reported in the EA/EEA in 2026, by week and at 5 August 2026.
By country (weekly) - Current season
Figure 8. Number of WNV outbreaks among equids and birds reported in the EA/EEA in 2026, by country and week and at 5 August 2026.
Outbreaks among equids
Overall (weekly)
Figure 9. Number of WNV outbreaks among equids reported in 2026, by week and at 5 August 2026.
Overall (monthly)
Figure 10. Number of WNV outbreaks among equids reported in 2026, by month, and during the previous 10 years, at 5 August 2026.
Equids - Current and Historical (monthly)
Figure 11. Number of WNV outbreaks among equids reported within Europe in 2026 and during the previous 10 years, by month at 5 August 2026.
Equids, comparison (weekly)
Figure 12. Comparison of number of WNV outbreaks among equids reported in the EA/EEA in 2026, and during the previous 5 years, at 5 August 2026.
Outbreaks among birds
Overall (weekly)
Figure 13. Number of WNV outbreaks among birds reported in 2026, by week and at 5 August 2026.
Overall (monthly)
Figure 14. Number of WNV outbreaks among birds reported in 2026, by month, and during the previous 4 years, at 5 August 2026.
Birds - Current and Historical (monthly)
Figure 15. Number of WNV outbreaks among birds reported within Europe in 2026 and during the previous 4 years, by month at 5 August 2026.
Birds, comparison (weekly)
Figure 16. Comparison of number of WNV outbreaks among birds reported in the EA/EEA in 2026, and during the previous 4 years, at 5 August 2026.
Maps
Human cases
Human cases - Current year
Figure 17. Spatial distribution of locally acquired human cases of WNV infections within Europe in 2026 by NUTS3 or GAUL 1 regions, at 5 August 2026.
Human cases - Historical - Affected regions
Figure 18. Spatial distribution of locally acquired human cases of WNV infections in NUTS3 or GAUL 1 regions within Europe during 2026, and during the last 10 years, at 5 August 2026.
Human cases - Historical - Count
Figure 19. Spatial distribution of locally acquired human cases of WNV infections in NUTS3 or GAUL 1 regions within Europe during the last 10 years, at 5 August 2026.
Animal outbreaks
Outbreaks in equids and/or birds - Current year
Figure 20. Spatial distribution of WNV outbreaks among equids and/or birds in NUTS 3 regions in the EU/EEA during 2026, at 5 August 2026.
Number of outbreaks in equids and/or birds - Current year
Figure 21. Spatial distribution of number of WNV outbreaks among equids and/or birds in NUTS 3 regions in the EU/EEA during 2026, at 5 August 2026.
Number of outbreaks in birds - Current year
Figure 22. Spatial distribution of number of WNV outbreaks among birds in NUTS 3 regions in the EU/EEA during 2026, at 5 August 2026.
